ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
A third cancer-causing impurity detected in U.S. supply of blood pressure drugs
March 05, 2019Just when it appeared the FDA was close to purging the U.S. drug supply of potential cancer-causing impurities in sartan blood pressure drugs, another massive recall has been launched. This time it is for an entirely new contaminant. -
Mylan recalls all lots of blood pressure drugs containing valsartan
December 10, 2018Mylan has expanded the consumer-level voluntary recall of all lots of valsartan-containing drugs within expiry in the US after finding trace amounts of an impurity called N-nitrosodiethylamine (NDEA).....
Pharma Sources Insight January 2025
